Hologic Inc (STU:HO1)
€ 72 -4.5 (-5.88%) Market Cap: 16.83 Bil Enterprise Value: 17.02 Bil PE Ratio: 23.66 PB Ratio: 3.57 GF Score: 87/100

Hologic Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 04:20PM GMT
Release Date Price: €68.42 (-1.06%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Hey, everyone. My name is Tejas Savant, and I'm the life science tools and diagnostics analyst here at Morgan Stanley. It's my pleasure to host Hologic this afternoon, and we have Karleen Oberton, CFO; and Ryan Simon from Investor Relations, representing the company.

Before we get started, just need to rattle off the disclosure statement here. Please see the Morgan Stanley disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your sales rep.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

So with that, guys, thanks for doing this. Maybe Karleen, just to set the stage, can you talk about sort of some of your key accomplishments over the last 12 months? And what are you looking forward to as you head into fiscal '23?

Karleen M. Oberton
Hologic, Inc. - CFO

Sure. Well, thank you, Tejas, and thanks for having us. We're excited to be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot